Treatment

Briquilimab clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihistamines
This study is testing a new medicine, briquilimab, for adults with chronic inducible urticaria (CIndU) – a type of chronic hives. We want to see if it's safe, how it works in the body, and if it helps reduce symptoms when other medicines haven't worked.
For: Chronic Inducible Urticaria
Germany